Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 3Other hematologic neoplasm 2Myeloid 1

Conditions

Hematologic Neoplasms 4Thrombocytopenia 2Hemorrhage 2Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1

Interventions

eltrombopag 9Platelet Transfusion 5Cytarabine 5Peripheral Blood Stem Cell Transplantation 3Daunorubicin 3fludarabine phosphate 2Tranexamic Acid 2Radiotherapy 2Lenalidomide 2Filgrastim 2Etoposide 2Cyclosporine 2Busulfan 2sargramostim 1oprelvekin 1ofatumumab 1leridistim 1bryostatin 1 1alvocidib 1Vitamin E 1Vincristine 1Transplantation 1Topotecan 1Thioguanine 1Surveys and Questionnaires 1Ritonavir 1Quality of Life 1Prednisone 1Microarray Analysis 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Thrombocytopenia × Tranexamic Acid × Other hematologic neoplasm × Clear all
NCT06599762 2026-04-22

MYELO-CAN:TXA

University of Manitoba

Phase 2 Recruiting
75 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Thrombocytopenia, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

NCT03801122 2023-05-06

TTRAP-Bleeding

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Completed
18 enrolled
Classical hematologyOther hematologic neoplasm

Hemorrhage, Thrombocytopenia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡